Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
about
Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer.Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review.A new receptor tyrosine kinase inhibitor, icotinib, for patients with lung adenocarcinoma cancer without indication for chemotherapy.Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group TriSmoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinomaComparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.A novel paradigm in the treatment of oligometastatic non-small cell lung cancer.Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implicationsPrognosis in lung cancer: physicians' opinions compared with outcome and a predictive modelDo patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer.Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.Determinants of survival in advanced non--small-cell lung cancer in the era of targeted therapiesHormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?Lung cancer and women.Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer.Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients.Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.Substantial risk affects the stage-dependent outcomes of cisplatin-based adjuvant chemotherapy for completely resected non-small cell lung cancer.Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients.Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer.Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer.Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients.[Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer].
P2860
Q27851860-0456C646-1D90-4715-B73A-5F15F4B2AE06Q33428648-FC10418F-3DBB-4839-8790-1DFD7C8D82E7Q33625469-E903C5EA-A7C4-428A-900B-CD89E26F34BEQ33669810-E5A01DFB-32BB-42B9-B337-25AD2D9E7F75Q33992482-B6769B60-5832-4586-A1C5-07ABC6251717Q34004381-CBC7F740-5ACB-419E-9F0B-C7424207FE6BQ34141560-7B058B46-B2C8-40F7-984C-B94C89CA2BA9Q34448438-C9FE6AB1-6420-46EA-A6DF-C0E86A906EB5Q34487100-C711A6BE-6288-4414-923E-3BD3EFCE44A0Q34786733-238D547B-5B9A-432A-A3F6-653AA4391C59Q35667792-A229E310-DCE3-4007-9D9C-63F534AE01E7Q35708619-28AE12AA-DE57-4BC1-AEAA-5547797A9363Q35874455-9847B57E-8CCB-4EAA-9E9A-D28200588AD7Q36114807-B99FBBB5-5263-412F-805B-50D3101CA8F5Q36393088-D3B7ED16-72EC-4618-9177-8F4DED60E149Q36431605-0F61D5BF-291E-4C82-9824-2E3BC3A613C3Q36467696-5AF68A25-C38E-4BBF-98E5-40133D0F26A8Q36500218-FD164791-8A89-4B11-92E2-C16D5E34720CQ36694116-C3E82EC7-824D-46DD-9484-60ED48285BAFQ36823770-C4F23F5C-B1EA-4818-9666-907D71CCEDC0Q36863492-FA4B1C30-5DE9-49F3-819F-FBF92FA2C9F3Q36924926-689BF5BA-261E-413B-B40E-5D6953FBDB23Q37146779-C8BEBB97-D41A-4E46-9902-5F7FF164432AQ37225785-41A7197E-E1B1-4FE1-BBB4-A83E502FBE4EQ37298672-7574EEA0-F457-4006-AEEA-E585FAF9F121Q37329410-1B563E20-32CF-4DDA-95ED-70FE646385D9Q40812688-9E5760F9-C320-4D8C-A199-4D1ADBE55B74Q41211903-B5AA5479-C04A-4013-A54A-B75B688A3227Q41517037-FC7DC70C-3507-43D4-969B-557803B15D5FQ43011817-D290DD47-1A35-4D02-92D0-8EA21EC96461Q43830793-D210F16F-8D8E-435E-91D8-06883D687369Q46670739-A7C0F630-6974-4294-95EB-351BBE515E79Q50050101-59E716CD-B7C9-4E4A-B3CB-C21AB22D49E2Q51023039-6DAEE821-E1AD-4B97-BEDA-EF88ED99BFB6Q55066021-0AF7233E-16E0-4AAA-870A-80D4DFE7F793Q55379148-A332AA9D-9E54-441F-87D1-BDE8CFC2713DQ55464870-BF8D65EB-DFED-41D4-8B42-782BF35A5017
P2860
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Frequency and prognostic impor ...... with combination chemotherapy.
@en
type
label
Frequency and prognostic impor ...... with combination chemotherapy.
@en
prefLabel
Frequency and prognostic impor ...... with combination chemotherapy.
@en
P2093
P1476
Frequency and prognostic impor ...... with combination chemotherapy.
@en
P2093
D P Kelsen
J P O'Connell
R B Golbey
R J Gralla
R T Heelan
P304
P356
10.1200/JCO.1986.4.11.1604
P407
P577
1986-11-01T00:00:00Z